Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,518 | 557 | 97.8% |
| Unspecified | $150.00 | 1 | 1.7% |
| Education | $38.24 | 4 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,200 | 139 | $0 (2024) |
| PFIZER INC. | $1,236 | 151 | $0 (2024) |
| Novo Nordisk Inc | $699.57 | 38 | $0 (2024) |
| AbbVie Inc. | $609.21 | 31 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $458.09 | 26 | $0 (2022) |
| Lilly USA, LLC | $437.95 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $424.63 | 20 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $367.36 | 23 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $309.04 | 17 | $0 (2023) |
| Abbott Laboratories | $305.55 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,117 | 67 | GlaxoSmithKline, LLC. ($302.16) |
| 2023 | $1,168 | 67 | GlaxoSmithKline, LLC. ($316.73) |
| 2022 | $1,091 | 60 | GlaxoSmithKline, LLC. ($319.26) |
| 2021 | $1,534 | 87 | Janssen Pharmaceuticals, Inc ($227.85) |
| 2020 | $829.23 | 48 | GlaxoSmithKline, LLC. ($247.91) |
| 2019 | $915.61 | 77 | GlaxoSmithKline, LLC. ($290.17) |
| 2018 | $1,165 | 89 | GlaxoSmithKline, LLC. ($235.01) |
| 2017 | $885.43 | 67 | GlaxoSmithKline, LLC. ($301.54) |
All Payment Transactions
562 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: RESPIRATORY | ||||||
| 11/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes Care | ||||||
| 11/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Diabetes Care | ||||||
| 10/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Cardio-renal | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: PAIN | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: VACCINES | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Diabetes Care | ||||||
| 08/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: RESPIRATORY | ||||||
| 08/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Cardio-renal | ||||||
| 07/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber/Pharmacist Knowledge, Attitudes and Behavior about SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) or the Authorized Generic of SUBOXONE Sublingual Film (CIII) Safety and Use Information | Indivior Inc. | $150.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 256 | 393 | $49,750 | $30,162 |
| 2022 | 7 | 357 | 482 | $58,845 | $34,437 |
| 2021 | 5 | 245 | 326 | $43,885 | $27,876 |
| 2020 | 6 | 294 | 415 | $49,560 | $24,500 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 190 | $28,500 | $15,054 | 52.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 75 | 75 | $12,000 | $9,715 | 81.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 70 | $7,350 | $4,171 | 56.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 37 | $1,480 | $1,161 | 78.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 16 | 21 | $420.00 | $61.26 | 14.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 228 | $34,200 | $18,033 | 52.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 66 | 66 | $10,560 | $8,896 | 84.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 84 | $8,820 | $4,806 | 54.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 53 | 54 | $2,160 | $1,654 | 76.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 13 | 15 | $1,575 | $712.85 | 45.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 19 | 19 | $570.00 | $181.07 | 31.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 16 | $960.00 | $153.74 | 16.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 164 | $24,600 | $13,722 | 55.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 78 | 78 | $12,480 | $10,852 | 87.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 26 | $2,730 | $1,618 | 59.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 25 | 27 | $2,835 | $1,136 | 40.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 30 | 31 | $1,240 | $549.23 | 44.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 98 | 167 | $17,535 | $7,371 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 58 | 58 | $9,280 | $7,022 | 75.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 66 | 103 | $15,450 | $6,440 | 41.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 41 | 55 | $5,775 | $3,187 | 55.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 19 | 20 | $800.00 | $351.20 | 43.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 12 | 12 | $720.00 | $128.84 | 17.9% |
About Dr. Gregory Steinmetz, MD
Dr. Gregory Steinmetz, MD is a Family Medicine healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043294630.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Steinmetz, MD has received a total of $8,706 in payments from pharmaceutical and medical device companies, with $1,117 received in 2024. These payments were reported across 562 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,518).
As a Medicare-enrolled provider, Steinmetz has provided services to 1,152 Medicare beneficiaries, totaling 1,616 services with total Medicare billing of $116,976. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Warwick, RI
- Active Since 12/06/2005
- Last Updated 02/14/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1043294630
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,465
- ELIQUIS (Drug) $566.46
- CHANTIX (Drug) $461.79
- XARELTO (Drug) $423.63
- JARDIANCE (Drug) $328.42
- Ozempic (Drug) $295.74
- BREO (Drug) $277.05
- FARXIGA (Drug) $247.98
- Creon (Drug) $210.50
- FREESTYLE LIBRE 3 (Device) $206.71
- Rybelsus (Drug) $198.29
- Kerendia (Drug) $196.63
- ANORO (Drug) $171.57
- QULIPTA (Drug) $157.59
- TRULICITY (Drug) $153.39
- BUPRENORPHINE AND NALOXONE (Drug) $150.00
- ANORO ELLIPTA (Drug) $147.91
- Prolastin-C (Biological) $138.57
- EMGALITY (Drug) $132.03
- NURTEC ODT (Drug) $128.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Warwick
Martin Kerzer, Do, DO
Family Medicine — Payments: $17,316
Carol Taylor, M.d, M.D
Family Medicine — Payments: $13,577
Dr. John Horan, Do, DO
Family Medicine — Payments: $12,909
Dr. Michael Rekas, D.o, D.O
Family Medicine — Payments: $12,250
David Coia, Do, DO
Family Medicine — Payments: $6,828
Keith Callahan, M.d, M.D
Family Medicine — Payments: $6,226